ESR1 and breast cancer: The use of IHC to assess the ER and PR status of breast cancers in formalin-fixed, paraffin-embedded (FFPE) tissue sections of cancer samples is now a routine part of pathology practice worldwide and is recommended to be performed in all primary invasive breast carcinomas and on recurrent or metastatic tumors.